Regency Fincorp board to consider NCD issuance, ESOPs on Sep 23
- Board meeting scheduled for September 23, 2026 to consider NCD issuance
- Agenda includes appointment of debenture trustee for private placement
- Company to consider ESOPs and preferential allotment of equity shares
- Proposal to increase authorized share capital and alter MOA

*this image is generated using AI for illustrative purposes only.
Regency Fincorp Limited has scheduled a board meeting for September 23, 2026. The directors will consider key corporate actions including debt issuance and equity restructuring.
The meeting agenda focuses on raising capital through multiple instruments. The company plans to issue listed, rated, secured, and redeemable non-convertible debentures via private placement. This requires appointing a debenture trustee to oversee the transaction.
Capital Structure Changes
The board will also review equity-related matters. These include issuing employee stock options to eligible staff subject to regulatory approvals. Additionally, the company proposes issuing equity shares, warrants, or compulsorily convertible debentures on a preferential basis.
To facilitate these issuances, the directors will consider increasing the authorized share capital. This move requires a consequential alteration of the Memorandum of Association.
Regulatory Compliance
The intimation was issued pursuant to Regulation 29 of Chapter IV and Regulation 50 of Chapter V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Abhimanyu, the Company Secretary and Compliance Officer, signed the notice dated September 19, 2026.
Historical Stock Returns for Regency Fincorp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.46% | -1.86% | -1.13% | +62.89% | +6.49% | +726.91% |
How might the proposed issuance of secured non-convertible debentures impact Regency Fincorp's debt-to-equity ratio and credit rating outlook?
What strategic initiatives or acquisitions is the company likely funding with the capital raised through this mixed instrument approach?
Could the preferential issue of equity shares and warrants lead to significant dilution for existing minority shareholders?


































